To decipher the potential involvement of the proteins upregulated in GDM-hAMSCs, we followed two approaches: pharmacological inhibition of protein function for FGFR2, TGFBR1 and PAI-1, and siRNA-mediated knockdown for VEGFA. This evidence concerns the gene TGFBR1 and gestational diabetes.